Home GTx

GTx

acquired
IPO
A biopharmaceutical company
Basic
Enterprise Profile

Basic Information

GTx is committed to developing novel targeted hormone therapies to provide patients with better medications. GTx focuses on the development of small molecules that selectively modulate the effects of certain hormones produced by the body. The company develops Selective Androgen Receptor Modulators, also known as SARMs, for the potential treatment of a variety of diseases.
GTx, Inc.
Memphis,Tennessee,United States of America
51~100 people
January 01, 1997
investor.relations@gtxinc.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations Biological Drug Production
Technology
Gene Technology Biotechnology